Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.01
-0.25 (-3.44%)
At close: Oct 16, 2025, 4:00 PM EDT
6.96
-0.05 (-0.71%)
Pre-market: Oct 17, 2025, 6:34 AM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $303.15 million as of October 17, 2025. Its market cap has increased by 48.54% in one year.
Market Cap
303.15M
Enterprise Value
97.39M
1-Year Change
48.54%
Ranking
Category
Stock Price
$7.01
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $303.15M, a decrease of -66.25%. That is a compound annual growth rate of -47.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 303.15M | 87.75% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.00B |
| Johnson & Johnson | 458.33B |
| AbbVie | 405.92B |
| UnitedHealth Group | 327.91B |
| AstraZeneca | 262.55B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.13B |
| Abbott Laboratories | 230.63B |